Santen Holdings EU B.V.
Santen SA Alias
Netherlands
Eye care product development
Research and development
Pharmaceutical research and development
Pharmaceutical manufacturing
Pharmaceutical sales and marketing
Eye health product and service provision
Prescription ophthalmic pharmaceuticals
Over-the-counter eye treatments
Medical devices
Nutritional products for eye health
Glaucoma treatment
Dry eye treatment
Eye infection treatments
Allergy treatments
Vision correction devices
Glaucoma surgery devices
Eye care product supply
Innovation labs
Eye care products
Glaucoma surgical device
Ocular surface disease treatments
Vision-saving solutions
Therapeutic treatments for ophthalmology
Medical devices for ophthalmology
Netherlands
Company name
Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
Boehringer Ingelheim
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Alliance
Singapore Eye Research Institute
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Alliance
twoXAR
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Alliance
InnFocus Inc.
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders

5 entries
DateDescription
1890 In 1890 in Osaka, Kenkichi Taguchi founded a private firm called Taguchi Santendo.
1899 In 1899 he launched Daigaku Eye Drops, a huge success that supported the company’s early growth and still marketed in Japan today.
1914 In 1914 Chuko Mita joined and it became a limited partnership company.
1925 Santendo Co. Ltd was established in 1925, with Chuko Mita as president.
1977 We were first listed on the Tokyo stock exchange in 1977.
+ Loaded when opened
2026-09-21 18:06 (Model: gpt-oss-20b(99) )
↑